EDGAR Filing Documents for 0001651844-15-000001

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0001651844-15-000001

Filing Date

2015-08-27

Accepted

2015-08-27 15:38:37

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	schedule13D.txt	SC 13D	4901
	Complete submission text file	0001651844-15-000001.txt		6200

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Subject) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-50514 | Film No.: 151078707
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 10 EAST LEE STREET SUITE 2705 BALTIMORE MD 21202

Business Address

Robinson James George (Filed by) CIK: 0001651844 (see all company filings)

Type: SC 13D